Author

HOSSAINOOR RAHAMAN SARENG

Bose Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Organism:Drosophila· 1

Frequent Co-Authors

Mahadeb PaliD· 2 shared Naibedya Dutta· 2 shared Anirban MannaiD· 1 shared Atin Kumar MandaliD· 1 shared Izaz Monir Kamal· 1 shared Jayanta MukhopadhyayiD· 1 shared Mohit PrasadiD· 1 shared Nilanjana GhoshiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Mahadeb PalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintDec 11, 2025

Epoxyazadiradione ameliorates Parkinson's disease by upregulating heat shock factor 1 and protein degradation pathways in mice.

Shivani Chandel, Naibedya Dutta, HOSSAINOOR RAHAMAN SARENG…·Mahadeb Pal

This paper identifies Epoxyazadiradione as a compound that improves Parkinson's disease symptoms in mice by enhancing heat shock factor 1 and protein degradation pathways without affecting redox balance.

DOI 10.64898/2025.12.08.692835

mouseproteomics

𝕏 PostBluesky

Molecular BiologybioRxivPreprintApr 9, 2025

HSF1 Activator Azadiradione Ameliorates Parkinson Disease and Extends Lifespan in Preclinical Models: Analysis of Underlying Molecular Mechanism

HOSSAINOOR RAHAMAN SARENG, Naibedya Dutta, Suvranil Ghosh…·Mahadeb Pal

This study shows that azadiradione enhances protein quality control mechanisms and alleviates Parkinson's disease symptoms in preclinical models.

1 citation

mouseDrosophila

𝕏 PostBluesky